 |
| TRTC Keeps the Green Days Rolling |
|
 Hot Stock to Watch |
Company: Terra Tech Corp (OTCQB: TRTC)
|
Last:
Price: 0.565
Change (%): + 0.069 (13.91)
Volume: 5,587,761 |
 |
Inergetics Appoints Yu Shao, Ph.D., as a Strategic Advisor for Development of CBD-Based Nutritional Supplements
Dr. Shao brings extensive experience in R&D, pharmaceutical extraction and the formulation of herbal and botanical products
NEWARK, N.J., March 5, 2014 /PRNewswire/ - Inergetics, Inc. (OTCBB: NRTI), a leading developer of nutritional supplements today announced the appointment of Yu Shao, Ph.D., as a strategic member of their Scientific/Medical Advisory Board and advisor, guiding the formulation of the proprietary line of natural Cannabidiol (CBD)-based nutritional supplements Inergetics and its partner Terra Tech (OTCBB: TRTC) are developing jointly.
Dr. Shao has extensive experience in product research and development across many areas of health and wellness, specializing in pharmaceutical extraction methods and plant biochemistry - as well as formulating herbal and botanical nutritional products. He brings almost two decades of expertise in these fields working with a variety of global firms, including Glaxo Smith Kline, Wyeth (now Pfizer), and Merck, directing the launch of more than 30 innovative new products for these companies.
Dr. Shao will work closely with Inergetics’ Chief Science Officer, Carl Germano, RD, CNS, CDN throughout the development process to ensure that the new CBD-based product lines are world-class in terms of medical effectiveness, quality, purity and safety.
Continue Reading |
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the "unsubscribe" link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
